Sun Heyuan, Liu Tong, Wang Zijian, Shen Wenjuan, Yuan Xingxing, Xie Jingri, Zhang Yang
Department of Internal Medicine, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150040, People's Republic of China.
Department of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, 150040, People's Republic of China.
Drug Des Devel Ther. 2025 Apr 28;19:3395-3406. doi: 10.2147/DDDT.S518547. eCollection 2025.
Chronic liver disease is a major global health concern, posing significant challenges due to its asymptomatic progression and the limitations of conventional treatments. Effective therapeutic strategies remain a pressing need. Curcumin, a natural polyphenolic compound derived from turmeric rhizomes, has demonstrated diverse pharmacological properties. Beyond its well-known antioxidant activity, curcumin exhibits anti-inflammatory, antiviral, and anti-fibrotic effects, along with the ability to regulate cellular autophagy and apoptosis. Recent studies suggest its potential to inhibit the progression of chronic liver disease through multiple molecular pathways. This review summarizes the latest research on curcumin's therapeutic effects in chronic liver disease, focusing on its mechanisms of action and clinical relevance. By integrating findings from experimental and clinical studies, we aim to provide novel insights into curcumin as a promising therapeutic candidate for liver disease management.
慢性肝病是一个重大的全球健康问题,因其无症状进展和传统治疗方法的局限性而带来重大挑战。有效的治疗策略仍然是迫切需要的。姜黄素是一种从姜黄根茎中提取的天然多酚化合物,已显示出多种药理特性。除了其众所周知的抗氧化活性外,姜黄素还具有抗炎、抗病毒和抗纤维化作用,以及调节细胞自噬和凋亡的能力。最近的研究表明,它有可能通过多种分子途径抑制慢性肝病的进展。本综述总结了关于姜黄素在慢性肝病治疗作用的最新研究,重点关注其作用机制和临床相关性。通过整合实验和临床研究的结果,我们旨在为姜黄素作为肝病管理中有前景的治疗候选物提供新的见解。